[go: up one dir, main page]

WO1996040057A3 - Reverse fluorocarbon emulsion compositions for drug delivery - Google Patents

Reverse fluorocarbon emulsion compositions for drug delivery Download PDF

Info

Publication number
WO1996040057A3
WO1996040057A3 PCT/US1996/009064 US9609064W WO9640057A3 WO 1996040057 A3 WO1996040057 A3 WO 1996040057A3 US 9609064 W US9609064 W US 9609064W WO 9640057 A3 WO9640057 A3 WO 9640057A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
emulsion compositions
fluorocarbon emulsion
emulsions
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1996/009064
Other languages
French (fr)
Other versions
WO1996040057A2 (en
Inventor
Thomas E Tarara
Jeffry G Weers
Leo A Trevino
Alexey Kabalnov
Luis A Dellamary
Gina M Hopper
Helen M Ranney
David H Klein
Timothy J Pelura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alliance Pharmaceutical Corp
Original Assignee
Alliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alliance Pharmaceutical Corp filed Critical Alliance Pharmaceutical Corp
Priority to IL12224996A priority Critical patent/IL122249A0/en
Priority to JP9501474A priority patent/JPH11508237A/en
Priority to EP96919114A priority patent/EP0833608A2/en
Priority to AU61537/96A priority patent/AU704918B2/en
Publication of WO1996040057A2 publication Critical patent/WO1996040057A2/en
Publication of WO1996040057A3 publication Critical patent/WO1996040057A3/en
Priority to NO975321A priority patent/NO975321L/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A polar liquid-in-perfluorochemical emulsion or microemulsion for use in delivery of therapeutic or diagnostic agents. These compositions are formed by combining a discontinuous aqueous phase, a continuous fluorocarbon phase and a nonfluorinated surfactant. Further, the polar liquid-in-fluorochemical emulsions may be used to form multiple emulsions having an aqueous continuous phase. Such emulsions and microemulsions are suitable for the administration of pharmaceutical agents including genetic material.
PCT/US1996/009064 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery Ceased WO1996040057A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IL12224996A IL122249A0 (en) 1995-06-07 1996-06-05 Fluorocarbon pharmaceutical formulations and their preparation
JP9501474A JPH11508237A (en) 1995-06-07 1996-06-05 Reversed phase fluorocarbon emulsion composition for drug delivery
EP96919114A EP0833608A2 (en) 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery
AU61537/96A AU704918B2 (en) 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery
NO975321A NO975321L (en) 1995-06-07 1997-11-19 Reverse fluorocarbon emulsion mixtures for drug delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48761295A 1995-06-07 1995-06-07
US08/487,612 1995-06-07

Publications (2)

Publication Number Publication Date
WO1996040057A2 WO1996040057A2 (en) 1996-12-19
WO1996040057A3 true WO1996040057A3 (en) 1997-02-20

Family

ID=23936452

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/009064 Ceased WO1996040057A2 (en) 1995-06-07 1996-06-05 Reverse fluorocarbon emulsion compositions for drug delivery

Country Status (11)

Country Link
EP (1) EP0833608A2 (en)
JP (1) JPH11508237A (en)
KR (1) KR19990022354A (en)
CN (1) CN1195981A (en)
AU (1) AU704918B2 (en)
CA (1) CA2222063A1 (en)
HU (1) HUP9900879A2 (en)
IL (1) IL122249A0 (en)
NO (1) NO975321L (en)
PL (1) PL323931A1 (en)
WO (1) WO1996040057A2 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1023058A2 (en) * 1997-10-24 2000-08-02 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
WO1999024016A1 (en) * 1997-11-10 1999-05-20 Sonus Pharmaceuticals, Inc. Emulsions for aerosolization and drug delivery
US6159917A (en) * 1998-12-16 2000-12-12 3M Innovative Properties Company Dry cleaning compositions containing hydrofluoroether
US6127430A (en) * 1998-12-16 2000-10-03 3M Innovative Properties Company Microemulsions containing water and hydrofluroethers
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6294153B1 (en) * 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US7087215B2 (en) 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6849263B2 (en) 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
EP1338272A1 (en) * 1998-12-21 2003-08-27 Generex Pharmaceuticals Inc. Aerosol formulations for buccal and pulmonary application comprising chenodeoxycholate or deoxycholate
US6271200B1 (en) * 1998-12-21 2001-08-07 Generex Pharmaceuticals Inc. Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US7357937B2 (en) * 2002-09-24 2008-04-15 Therox, Inc. Perfluorocarbon emulsions with non-fluorinated surfactants
GB0307403D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
AU2003903296A0 (en) * 2003-06-30 2003-07-10 Raustech Pty Ltd Chemical compositions of matter
EP1815869A4 (en) * 2004-11-24 2011-04-06 Nanocarrier Co Ltd METHOD FOR CHANGING MORPHOLOGY OF A COPOLYMER SEQUENCE
AU2006335290A1 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
EP2021113A2 (en) 2006-05-11 2009-02-11 Raindance Technologies, Inc. Microfluidic devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
FR2903602B1 (en) * 2006-07-12 2012-10-26 Seppic Sa INJECTABLE FORMULATION WITH PROLONGED RELEASE OF ACTIVE INGREDIENTS, PROCESS FOR PREPARING THE SAME
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
AU2009206391A1 (en) * 2008-01-22 2009-07-30 Board Of Regents, The University Of Texas System Volatile anesthetic compositions and methods of use
EP2123256A1 (en) * 2008-05-19 2009-11-25 Ruhr-Universität Bochum Perfluorcarbon nanoemulsions with endocytosis enhancing surface for gene-transfer
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010009365A1 (en) 2008-07-18 2010-01-21 Raindance Technologies, Inc. Droplet libraries
EP2411148B1 (en) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation of microfluidic droplets
EP3392349A1 (en) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9351943B2 (en) * 2010-07-01 2016-05-31 Matthew T. McLeay Anti-fibroblastic fluorochemical emulsion therapies
EP2587917A4 (en) * 2010-07-01 2015-05-06 Mtm Res Llc THERAPIES USING ANTIFIBROBLASTIC FLUOROCHEMICAL EMULSIONS
WO2012073856A1 (en) * 2010-11-29 2012-06-07 千寿製薬株式会社 Oil-in-water emulsion composition containing difluprednate and tobramycin
US9150852B2 (en) 2011-02-18 2015-10-06 Raindance Technologies, Inc. Compositions and methods for molecular labeling
SG194013A1 (en) * 2011-03-31 2013-11-29 Konstanze Schaefer Perfluorinated compounds for the non-viral transfer of nucleic acids
US9556470B2 (en) 2011-06-02 2017-01-31 Raindance Technologies, Inc. Enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US9801959B2 (en) * 2014-06-12 2017-10-31 Microvascuar Therapeutics Llc Phospholipid composition and microbubbles and emulsions formed using same
US9699301B1 (en) * 2015-05-31 2017-07-04 Emma Michaela Siritzky Methods, devices and systems supporting driving and studying without distraction
CN109908085B (en) * 2019-04-23 2021-12-03 董红燕 Respiratory tract administration medicine carrier, its preparation method and application in preparing medicine for treating heart disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033447A1 (en) * 1994-06-09 1995-12-14 Alliance Pharmaceutical Corp. Stable reverse and multiple fluorocarbon emulsions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995033447A1 (en) * 1994-06-09 1995-12-14 Alliance Pharmaceutical Corp. Stable reverse and multiple fluorocarbon emulsions

Also Published As

Publication number Publication date
IL122249A0 (en) 1998-04-05
CN1195981A (en) 1998-10-14
EP0833608A2 (en) 1998-04-08
PL323931A1 (en) 1998-04-27
NO975321D0 (en) 1997-11-19
HU9900879D0 (en) 1999-05-28
WO1996040057A2 (en) 1996-12-19
MX9709561A (en) 1998-10-31
CA2222063A1 (en) 1996-12-19
AU704918B2 (en) 1999-05-06
JPH11508237A (en) 1999-07-21
AU6153796A (en) 1996-12-30
KR19990022354A (en) 1999-03-25
HUP9900879A2 (en) 1999-08-30
NO975321L (en) 1998-01-27

Similar Documents

Publication Publication Date Title
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
CA2274773A1 (en) Aqueous therapeutic agents of ibuprofen
AU643690B2 (en) Injectable multi-phase emulsions
WO1999056727A3 (en) Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
CA2313024A1 (en) Pharmaceutical compositions containing an omega-3 fatty acid oil
DK0850046T3 (en) Microemulsions for use as vehicle for administration of active compounds
IS4224A (en) A pharmaceutical formulation in the form of a droplet containing a short-acting calcium antidote of the dihydropyridine antidepressant
KR950031069A (en) How to suppress bone loss and lower serum cholesterol
CA2296244A1 (en) Adjuvants for use in vaccines
GR3031523T3 (en) Stable reverse and multiple fluorocarbon emulsions
MA23344A1 (en) NEW EMULSION COMPOSITIONS
PT731688E (en) FORMULATIONS OF AEROSOL DRUGS FOR USE WITH CFC-FREE PROPULSORS
NO306894B1 (en) Use of galanthamine for the preparation of a pharmaceutical formulation for the treatment of nicotine addiction
ITMI921831A1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF MICROEMULSIONS OR BIOADHESIVE LIPOSOMIAL DISPERSIONS FOR THE TRANSMUCOSAL ADMINISTRATION OF PEPTIDAL SUBSTANCES AND PHARMACOLOGICALLY ACTIVE PROTEINS
WO2003082222A3 (en) Cosmetic or pharmaceutical low-viscosity (atomizable) o/w emulsions containing phospholipids
DE50012930D1 (en) EMULSIFY FREE WATER-IN-OIL WATER-DISPERSED SYSTEMS
WO2001007058A3 (en) Parenteral cisplatin emulsion
SE9402455L (en) Biskiktspreparat
DE69926633D1 (en) INJECTABLE MEDICINE PREORMULATIONS OF PARTRICINE DERIVATIVES
IT1254458B (en) Microemulsions of lipid substances for therapeutic use which are suitable for parenteral administration
MY118379A (en) Therapeutic agents.

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96195973.8

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 310703

Country of ref document: NZ

ENP Entry into the national phase

Ref document number: 2222063

Country of ref document: CA

Ref document number: 2222063

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1997/009561

Country of ref document: MX

Ref document number: 1019970708834

Country of ref document: KR

ENP Entry into the national phase

Ref document number: 1997 501474

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1996919114

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996919114

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1019970708834

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 1996919114

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1996919114

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1019970708834

Country of ref document: KR